Cargando…

The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia

Objective:Namibia faces a dual burden of HIV/AIDS and tuberculosis (TB). In 2010, HIV prevalence was 18.8%, the TB case notification rate was 634 cases per 100,000 population and the TB/HIV co-infection rate was 58%. There were 372 cases of drug-resistant TB (DR-TB) in 2009. The objective of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagwa, Evans, Mantel-Teeuwisse, Aukje Kaija, Ruswa, Nunurai, Musasa, Jean Paul, Pal, Shanthi, Dhliwayo, Panganai, van Wyk, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dr. Zaheer-Ud-Din Babar 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471190/ https://www.ncbi.nlm.nih.gov/pubmed/23093894

Ejemplares similares

Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia
por: Sagwa, Evans L, et al.
Publicado: (2016)

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
por: Sagwa, Evans L, et al.
Publicado: (2014)

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort
por: Sagwa, Evans L., et al.
Publicado: (2015)

Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia
por: Kibuule, Dan, et al.
Publicado: (2020)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Drug-resistant tuberculosis: advances in diagnosis and management
por: Günther, Gunar, et al.
Publicado: (2022)

Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia
por: Claassens, M., et al.
Publicado: (2022)

Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study
por: Ogar, Comfort K., et al.
Publicado: (2023)

Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana
por: Tetteh, Raymond A., et al.
Publicado: (2015)

Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients
por: Tetteh, Raymond A., et al.
Publicado: (2016)

The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study
por: Jacobs, Tom G., et al.
Publicado: (2018)

The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis
por: Lazarus, Gilbert, et al.
Publicado: (2021)

Implementing an Integrated Pharmaceutical Management Information System for Antiretrovirals and Other Medicines: Lessons From Namibia
por: Mabirizi, David, et al.
Publicado: (2018)

Case-Finding Strategies for Drug-Resistant Tuberculosis: Protocol for a Scoping Review
por: Van Wyk, Susanna S, et al.
Publicado: (2022)

Estimated Burden of Fungal Infections in Namibia
por: Dunaiski, Cara M., et al.
Publicado: (2019)

Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis
por: Mengistu, Assegid, et al.
Publicado: (2013)

The effects of Teen Clubs on retention in HIV care among adolescents in Windhoek, Namibia
por: Munyayi, Farai K., et al.
Publicado: (2020)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda
por: Kibira, Denis, et al.
Publicado: (2017)

Characteristics of multidrug-resistant tuberculosis in Namibia
por: Ricks, Philip M, et al.
Publicado: (2012)

Incorporating pharmaceutical supply management modules in the pre-service curriculum of the BPharm program, of the University of Namibia, School of Pharmacy
por: Mazibuko, Greatjoy Njabulo, et al.
Publicado: (2014)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Characteristics of drugs safety signals that predict safety related product information update
por: Insani, Widya N., et al.
Publicado: (2018)

The double opioid crisis: A call for balance
por: Vranken, Marjolein J.M., et al.
Publicado: (2019)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020)

Linking market authorizations of medicines with disease burden in South Africa
por: Narsai, K., et al.
Publicado: (2021)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2015)

Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study
por: Ankrah, Daniel N. A., et al.
Publicado: (2017)

Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study
por: Joosse, Iris R, et al.
Publicado: (2023)

When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
por: Callenbach, Marcelien H. E., et al.
Publicado: (2022)

The Comparison of Teen Clubs vs. Standard Care on Treatment Outcomes for Adolescents on Antiretroviral Therapy in Windhoek, Namibia
por: Munyayi, Farai K., et al.
Publicado: (2020)

Closing the HIV Treatment Gap for Adolescents in Windhoek, Namibia: A Retrospective Analysis of Predictors of Viral Non-Suppression
por: Munyayi, Farai Kevin, et al.
Publicado: (2022)

Essential Medicines Are More Available than Other Medicines around the Globe
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Real World Data in Health Technology Assessment of Complex Health Technologies
por: Hogervorst, Milou A., et al.
Publicado: (2022)

Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study
por: Dankers, Marloes, et al.
Publicado: (2022)

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019
por: Kusynová, Zuzana, et al.
Publicado: (2022)

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements
por: Dankers, Marloes, et al.
Publicado: (2023)

National medicines policies – a review of the evolution and development processes
por: Hoebert, Joëlle M, et al.
Publicado: (2013)

Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis
por: A Vreman, Rick, et al.
Publicado: (2020)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gimvbekmdes8bt61eid9rv0vtr